Yuki Noguchi
Yuki Noguchi is a correspondent on the Science Desk based out of NPR's headquarters in Washington, D.C. She started covering consumer health in the midst of the pandemic, reporting on mental health, vaccination, telehealth, and racial inequities in healthcare.
Noguchi started her career as a reporter, then an editor, for The Washington Post, primarily covering business and technology. Noguchi joined NPR as a business correspondent in 2008, just before the financial crisis and Great Recession. She has covered a wide range of issues, from the workplace to the earthquake and tsunami in her parents' native Japan in 2011. Her coverage of the impact of opioids on workers and their families won a 2019 Gracie Award as well as First Place and Best In Show in the radio category from the National Headliner Awards. Her work on medical debt, in partnership with Kaiser Health News, won a 2023 Gerald Loeb award and an award from the National Institutes of Health Care Management.
Noguchi grew up in St. Louis, likes to cook, has a degree in history from Yale and is raising two boys and two rescue dogs outside Washington DC.
-
Medicare patients have embraced telehealth -- it's convenient and efficient. But many can't get it during the government shutdown.
-
Like many Americans, Scott Adams had insurance problems. But unlike most people he has powerful friends on social media, and when he asked President Trump for help, he got the cancer drug he needed. -
The Gallup National Health and Well-Being Index shows that GLP-1 weight loss drugs are having an effect: The U.S. obesity rate is at 37%, down from 39.9%. -
Conspiracy theories about health fill a vacuum created by the lack of doctors in many rural communities. Meanwhile, doctors in these areas say patients have become increasingly distrustful and sometimes hostile. -
A new poll shows trust in federal health policies is plummeting, and what — or who — people believe increasingly depends on their politics. -
President Trump says an old drug that acts like a vitamin can reduce autism symptoms in many children. The science doesn't support that claim. -
Parents of children with autism speak out after Trump linked Tylenol use to autism and promoted leucovorin as a possible treatment, raising concern and confusion.
-
The president and his deputies tied autism to acetaminophen use during pregnancy, presented a cancer drug as possible treatment and said the FDA would change labeling. There's little strong scientific evidence for either. -
The Trump administration's document about children's health and chronic disease doesn't mention the word "nicotine" once. Tobacco remains the top cause of preventable death in the U.S. -
A report that health secretary Robert F. Kennedy, Jr. has promised will come out this month will look at the causes of autism. Many worry it will have claims unsupported by science.
